GARS1 and Alzheimer disease: It is noteworthy that artemisinins were reported to effectively control epileptic seizures in AD-independent conditions [45], which indicates that the effects of artesunate on GlyRs, and in general on inhibitory neurotransmission in the AD brain, cannot simply be the result of their anti-amyloidogenic properties.